Vimarsana
Biggest News Aggregation in the World

Page 5 - Robert Blum News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robert Blum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robert Blum Today - Breaking & Trending Today

Precision Optics Reports Second Quarter Fiscal Year 2024 Financial Results - Vimarsana News

Precision Optics Reports Second Quarter Fiscal Year 2024 Financial Results

Precision Optics Corporation, Inc. , a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its second quarter fiscal year 2024 for the period...

Precision Optics Reports Second Quarter Fiscal Year 2024 Financial Results - Vimarsana News

Precision Optics Reports Second Quarter Fiscal Year 2024 Financial Results

Precision Optics Reports Second Quarter Fiscal Year 2024 Financial Results

Precision Optics Reports Second Quarter Fiscal Year 2024 Financial Results - Vimarsana News

Precision Optics Reports Second Quarter Fiscal Year 2024 Financial Results

/PRNewswire/ -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and...

SenesTech Announces Exclusive Distribution Agreement for Evolve™ Soft Bait in Australia and New Zealand -February 08, 2024 at 09:01 am EST - Vimarsana News

SenesTech Announces Exclusive Distribution Agreement for Evolve™ Soft Bait in Australia and New Zealand -February 08, 2024 at 09:01 am EST

PHOENIX, Feb. 8, 2024 /PRNewswire/ -- SenesTech, Inc. , the leader in fertility control to manage animal pest populations, today announces entry into a Distribution Agreement with Evicom, an...

Cadrenal Therapeutics Appoints Jeff Cole as Chief Operating Officer in Advance of Tecarfarin Phase 3 Pivotal Trial - Vimarsana News

Cadrenal Therapeutics Appoints Jeff Cole as Chief Operating Officer in Advance of Tecarfarin Phase 3 Pivotal Trial

PONTE VEDRA, Fla., Feb. 8, 2024 /PRNewswire/ -- Cadrenal Therapeutics, Inc. , a biopharmaceutical company developing tecarfarin, a novel Vitamin K Antagonist for unmet needs in anticoagulation ...